TherapeuticsMD, Inc. ( TXMD) - Stock Earnings
TXMD Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 17, 2026, midnight | — / — | — | — / — | — |
TXMD Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -619000 USD | 893000 USD |
| 2026Q1 | 95000 USD | 724000 USD |
| 2026Q2 | 155000 USD | 869000 USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
TXMD Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -10.3 million USD | 1.3 million USD |
| 2024 | -2.2 million USD | 1.8 million USD |
| 2025 | -569000 USD | 3.0 million USD |
| 2026 Est. | — | — |
TXMD
Price: $1.80
Earnings Per Share: -0.03 USD
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 688
Ebitda: -21.6 millionMarket Capitalization: 23.7 million